ey0020.9-2 | New Findings in Adipose Tissue | ESPEYB20
M Emont , C Jacobs , AL Essene , D Pant , D Tenen , G Colleluori , A Di Vincenzo , AM Jorgensen , H Dashti , A Stefek , E McGonagle , S Strobel , S Laber , S Agrawal , GP Westcott , A Kar , ML Veregge , A Gulko , H Srinivasan , Z Kramer , E De Felippis , E Merkel , J Ducie , CG Boyd , W Gourash , A Courcoulas , SJ Lin , BT Lee , D Morris , A Tobias , AV Khera , M Claussnitzer , TH Pers , A Giodano , O Askenberg , A Regev , LT Tsai , ED Rosen
ey0019.9-1 | Cancer treatment and growth hormone therapy: a consensus | ESPEYB19
MCS Boguszewski , CL Boguszewski , W Chemaitilly , LE Cohen , J Gebauer , C Higham , AR Hoffman , M Polak , KCJ Yuen , N Alos , Z Antal , M Bidlingmaier , BMK Biller , G Brabant , CSY Choong , S Cianfarani , PE Clayton , R Coutant , AA Cardoso-Demartini , A Fernandez , A Grimberg , K Guðmundsson , J Guevara-Aguirre , KKY Ho , R Horikawa , AM Isidori , JOL Jorgensen , P Kamenicky , N Karavitaki , JJ Kopchick , M Lodish , X Luo , AI McCormack , L Meacham , S Melmed , Moab S Mostoufi , HL Muller , SJCMM Neggers , Oliveira MH Aguiar , K Ozono , PA Pennisi , V Popovic , S Radovick , L Savendahl , P Touraine , HM van Santen , G Johannsson
ey0020.7-14 | Long-Term Surveillance for Endocrine Complications in Childhood Cancer Survivors | ESPEYB20
L van Iersel , RL Mulder , C Denzer , LE Cohen , HA Spoudeas , LR Meacham , E Sugden , AYN Schouten-van Meeteren , EW Hoving , RJ Packer , GT Armstrong , S Mostoufi-Moab , AM Stades , D van Vuurden , GO Janssens , C Thomas-Teinturier , RD Murray , N Di Iorgi , SJCMM Neggers , J Thompson , AA Toogood , H Gleeson , C Follin , E Bardi , L Torno , B Patterson , V Morsellino , G Sommer , SC Clement , D Srivastava , CE Kiserud , A Fernandez , K Scheinemann , S Raman , KCJ Yuen , WH Wallace , LS Constine , R Skinner , MM Hudson , LCM Kremer , W Chemaitilly , HM van Santen
ey0020.13-1 | Section | ESPEYB20
P Singh , K Gollapalli , S Mangiola , D Schranner , MA Yusuf , M Chamoli , SL Shi , B Lopes Bastos , T Nair , A Riermeier , EM Vayndorf , JZ Wu , A Nilakhe , CQ Nguyen , M Muir , MG Kiflezghi , A Foulger , A Junker , J Devine , K Sharan , SJ Chinta , S Rajput , A Rane , P Baumert , M Schonfelder , F Iavarone , G di Lorenzo , S Kumari , A Gupta , R Sarkar , C Khyriem , AS Chawla , A Sharma , N Sarper , N Chattopadhyay , BK Biswal , C Settembre , P Nagarajan , KL Targoff , M Picard , S Gupta , V Velagapudi , AT Papenfuss , A Kaya , MG Ferreira , BK Kennedy , JK Andersen , GJ Lithgow , AM Ali , A Mukhopadhyay , A Palotie , G Kastenmuller , M Kaeberlein , H Wackerhage , B Pal , VK Yadav
ey0016.15-5 | (1) | ESPEYB16
E Voerman , S Santos , B Patro Golab , P Amiano , F Ballester , H Barros , A Bergstrom , MA Charles , L Chatzi , C Chevrier , GP Chrousos , E Corpeleijn , N Costet , S Crozier , G Devereux , M Eggesbo , S Ekstrom , MP Fantini , S Farchi , F Forastiere , V Georgiu , KM Godfrey , D Gori , V Grote , W Hanke , I Hertz-Picciotto , B Heude , D Hryhorczuk , RC Huang , H Inskip , N Iszatt , AM Karvonen , LC Kenny , B Koletzko , LK Kupers , H Lagstrom , I Lehmann , P Magnus , R Majewska , J Makela , Y Manios , FM McAuliffe , SW McDonald , J Mehegan , M Mommers , CS Morgen , TA Mori , G Moschonis , D Murray , CN Chaoimh , EA Nohr , AM Nybo Andersen , E Oken , A Oostvogels , A Pac , E Papadopoulou , J Pekkanen , C Pizzi , K Polanska , D Porta , L Richiardi , SL Rifas-Shiman , L Ronfani , AC Santos , M Standl , C Stoltenberg , E Thiering , C Thijs , M Torrent , SC Tough , T Trnovec , S Turner , L van Rossem , A von Berg , M Vrijheid , TGM Vrijkotte , J West , A Wijga , J Wright , O Zvinchuk , TIA Sorensen , DA Lawlor , R Gaillard , VWV Jaddoe
ey0015.9-11 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15
A Assa , M Amitai , ML Greer , DA Castro , RC Kuint , M Martínez-León , I Herman-Sucharska , E Coppenrath , S Anupindi , A Towbin , D Moote , O Konen , LT Pratt , A Griffiths , D Turner , ImageKids Study Group
ey0015.11-18 | Prebiotics reduce fat mass | ESPEYB15
AC Nicolucci , MP Hume , I Martínez , S Mayengbam , J Walter , RA Reimer
ey0016.9-15 | Biologic Agents and Growth in Chronic Inflammatory Diseases | ESPEYB16
KN Bharucha , HI Brunner , I Calvo Penades , I Nikishina , N Rubio-Perez , S Oliveira , K Kobusinska , H Schmeling , F Sztajnbok , F Weller-Heinemann , E Zholobova , F Zulian , R Allen , J Chaitow , J Frane , C Wells , N Ruperto , F De Benedetti
ey0015.2-10 | MEHMO syndrome is a novel X-linked retardation syndrome associated with neonatal hypoglycaemia, hypopituitarism and early onset diabetes mellitus | ESPEYB15
S Moortgat , J Désir , V Benoit , S Boulanger , H Pendeville , MC Nassogne , D Lederer , I Maystadt
ey0017.6-9 | Differences/Disorders of Sex Development: Genetics | ESPEYB17
JJ Hughes , E Alkhunaizi , P Kruszka , LC Pyle , DK Grange , SI Berger , KK Payne , D Masser-Frye , T Hu , MR Christie , NJ Clegg , JL Everson , AF Martinez , LE Walsh , E Bedoukian , MC Jones , CJ Harris , KM Riedhammer , D Choukair , PY Fechner , MM Rutter , SB Hufnagel , M Roifman , GB Kletter , E Delot , E Vilain , RJ Lipinski , CM Vezina , M Muenke , D Chitayat